ISSDP

The International Society for the Study of Drug Policy

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
The International Society for the Study of Drug Policy
English Español
  • Conferences & Events
    • Future Conferences & Events
    • Past Conferences & Events
    • Webinars
    • Past Webinars
    • Webinar Recordings (for Members)
  • News and Announcements
    • Current News & Announcements
    • Newsletters
    • Archived News & Announcements
  • Bibliography
    • Introduction
    • All Publications
    • Bibliography Archive
    • Prevalence
    • Production and Supply
    • Economics
    • Domestic Policy Issues
    • International Policy Issues
    • Interventions – Prevention
    • Interventions – Treatment
    • Interventions – Law Enforcement
    • Interventions – Harm Reduction
  • Membership
  • Who we are
  • Working Group
  • By-laws
  • Annual Awards
  • IJDP

Archives for February 2023

Bibliography: All Publications


New EMCDDA work programme prepares agency for significant changes ahead

27th February 2023

the latest EMCDDA work programme, which outlines our activities for 2023–2025

Categories: Bibliography, International Policy Issues

Categories: International Policy Issues

How England is eliminating hepatitis C

22nd February 2023

This report explores the development of the programme, how several of the key initiatives have worked and developed over time, and next steps in the programme (HCV Action)

Categories: Bibliography, Interventions - Harm Reduction

Categories: Interventions - Harm Reduction

Synthetic opioids will be banned as government acts to stop drug deaths

6th February 2023

Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)

Categories: Bibliography, Domestic Policy Issues, Interventions - Harm Reduction

Categories: Domestic Policy Issues, Interventions - Harm Reduction

Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists

3rd February 2023

From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)

Categories: Bibliography, Domestic Policy Issues, Interventions - Treatment

Categories: Domestic Policy Issues, Interventions - Treatment

Hepatitis C in the UK 2023

3rd February 2023

Working to eliminate hepatitis C as a public health threat (Health Security Agency)

Categories: Bibliography, Interventions - Harm Reduction, Interventions - Prevention, Interventions - Treatment, Prevalence

Categories: Interventions - Harm Reduction, Interventions - Prevention, Interventions - Treatment, Prevalence

Substance misuse treatment for young people: statistics 2021 to 2022

3rd February 2023

Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

Impact of the California Harm Reduction Initiative

1st February 2023

RTI’s National Survey of Syringe Service Programs (SSPs) showed that California’s investment in harm reduction yielded high levels of life-saving interventions in its three years of existence

Categories: Bibliography, Interventions - Harm Reduction

Categories: Interventions - Harm Reduction

Search the Bibliography

Bibliography Menu

  • Introduction
  • All Publications
  • Prevalence
  • Production and Supply
  • Economics
  • Domestic Policy Issues
  • International Policy Issues
  • Interventions – Prevention
  • Interventions – Treatment
  • Interventions – Law Enforcement
  • Interventions – Harm Reduction

Bibliography Archive

calendar-iconBibliography Archive ››

Navigation

  • Home
  • Future Conferences & Events
  • News & Announcements
  • Bibliography
  • Working Group
  • Annual Awards
  • Membership
  • Who we are
  • By-laws
  • IJDP
  • Contact

ISSDP on Twitter

Tweets by @ISSDrugPolicy

Contact ISSDP

For further information about the ISSDP, including membership queries, please contact us.

Please Share ISSDP

Copyright © 2023 The International Society for the Study of Drug Policy

The International Society for the Study of Drug Policy is registered in England as a charitable incorporated organisation. Charity no: 1177654